Nov 30, 2020 05:37 PM IST
The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.
- Nov 29, 2020 08:23 PM IST
The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India
- Nov 28, 2020 02:40 PM IST
The participant received the vaccine on October 1 and on October 11, he started experiencing severe headaches and was not able to respond to questions, said the notice to Serum Institute of India
- Nov 26, 2020 03:41 PM IST
Despite none of the Chinese firms has released any public data on the efficacy of their shots in Phase III trials, people in the Asian countries are bending the rules to get hold of the unproven Chinese vaccines.
- Nov 24, 2020 11:16 AM IST
If the vaccine is approved by the UK authorities, Serum Institute could also apply for emergency use in India based on the same data, Dr Guleria, a member of the Centre’s task force on vaccines, has said.
- Nov 23, 2020 09:35 PM IST
AstraZeneca announced that its COVID-19 vaccine's clinical trials in Brazil and the United Kingdom had shown higher effectiveness in combating the infection.
- Nov 23, 2020 09:26 PM IST
The SII remains in discussion with the Indian government about inking a purchase agreement for the vaccine.
- Nov 16, 2020 11:52 PM IST
Moderna on Monday said the independent National Institutes of Health-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vac.
- Sep 30, 2020 02:13 PM IST
Serum Institute will get the additional fund via the Foundation’s Strategic Investment Fund, taking the total funding from the collaboration to $300 million
- Sep 15, 2020 02:18 PM IST
He also pointed out that distribution of vaccines will be a “huge challenge”, but “cheap, quick and non-invasive testing and social distancing” should mitigate transmission in the meantime.
- Sep 13, 2020 02:00 PM IST
Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine have resumed in the UK
- Feb 18, 2017 12:54 PM IST
As per Cipla's co-exclusive agreement with SII, the former will market the vaccine for adults while the latter will market it for adults and children, a company statement said.
- Nov 14, 2011 02:55 PM IST
A couple months back, news about a different variant of the Samsung Galaxy S II popped up bearing the codename I9100G ...